UBS Group
LOACW

UBS Group’s Longevity Acquisition Corporation Warrant LOACW Stock Holding History

UBS Group’s Portfolio LOACW Stock Details LOACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,234
Closed -$7K – 9860
2020
Q4 		$7K Buy
+4,234
New +$2.95K ﹤0.01% 7737

UBS Group's LOACW Position: Q1 2021 in Review

UBS Group sold out of Longevity Acquisition Corporation Warrant (LOACW) in Q1 2021, closing a stake of 4,234 shares — an estimated $7K sold.

UBS Group first reported a position in LOACW in Q4 2020 and held it in 1 quarter. The position peaked at $7K in Q4 2020. 0 funds tracked by Wall St. Rank hold LOACW as of Q1 2021.

  • UBS Group reported no remaining Longevity Acquisition Corporation Warrant position as of Q1 2021 after selling out during the quarter.
  • UBS Group sold 4,234 Longevity Acquisition Corporation Warrant shares in Q1 2021, an estimated $7K.
  • UBS Group first reported a position in Longevity Acquisition Corporation Warrant in Q4 2020 and held it in 1 quarter.
  • UBS Group's Longevity Acquisition Corporation Warrant position peaked at $7K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Warrant as of Q1 2021.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.